News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
Presentation CTO 2023 How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me? Presenter: Ajay Kirtane February 23, 2023
News Daily News SCAI Updates Position on Doing PCI Without Surgical Backup Michael O'Riordan February 20, 2023
News Daily News Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM Yael L. Maxwell February 15, 2023
News Daily News Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL Michael O'Riordan February 15, 2023
News Daily News Intravascular Imaging to Inform PCI Should Be Routine: ACC Interventional Council Yael L. Maxwell February 13, 2023
News Daily News Prehospital Troponin Testing With EMS Input Could Save a Lot of Money Michael O'Riordan February 07, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2023 Caitlin E. Cox February 01, 2023
News Conference News STS 2023 Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG Yael L. Maxwell January 30, 2023
News Conference News STS 2023 Large Medicare Analysis Reopens Debate Over Multivessel Revascularization Yael L. Maxwell January 24, 2023
News Conference News STS 2023 Risk Stratify to Avoid Postcardiotomy Shock Following CV Surgery Yael L. Maxwell January 23, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Daily News Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3 Michael O'Riordan January 16, 2023
News Daily News Brachytherapy Remains an Option for DES In-Stent Restenosis Yael L. Maxwell January 12, 2023
News Daily News CT Angiography Is Increasing in England, but Downstream Tests Are Not Michael O'Riordan January 12, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023